French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
MCM Vaccines B.V.
Other / Industry
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
HIV-infected patients who seroconvert in the first two months after the last vaccination. Seroconversion is defined as antibodies AbHBs titers equal or above 10 mUI per ml.
According to the vaccine administration (IM or ID) comparison of AbHBs titers,permanence of the humoral response,intensity of clinical and biological events and predicting factors related to seroconversion
18 Years and older (Adult, Senior)
2006-003940-50 ANRS HB 03 VIHVAC-B
May 31, 2007
July 23, 2013
Hopital Cochin CIC de vaccinologie Paris, France
† Study has passed its completion date and status has not been verified in more than two years.